VIA EDGAR
June 7, 2024
United States Securities and Exchange Commission
Office of Life Sciences
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Ainos, Inc. |
Acceleration Request for Registration Statement on Form S-3 | |
File No. 333-279880 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Ainos, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 11, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Lucosky Brookman LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with the Company by calling Lawrence K. Lin at 310-869-4870. If you have any questions regarding this request, please contact Lawrence K. Lin at 310-869-4870.
Sincerely, | |
Ainos, Inc. | |
/s/ Chun-Hsien Tsai | |
Chun-Hsien Tsai | |
Chairman of the Board, President and Chief Executive Officer |
cc: | Christopher Hsin-Liang Lee |
Steven A. Lipstein, Esq. |